Price target
3,372.00RINR+597.40+21.53%
The 1 analyst offering 1 year price forecasts for LUMAX INDUSTRIES LTD have a max estimate of 3,372.00 and a min estimate of 3,372.00.
Analyst rating
Based on 1 analyst giving stock ratings to LUMAX INDUSTRIES LTD in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
11.00
22.00
33.00
44.00
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
20.30
28.08
27.30
38.60
36.10
30.10
34.70
—
—
Estimate
38.00
42.60
40.10
32.80
—
32.90
27.30
32.70
—
Surprise
−46.58%
−34.08%
−31.92%
+17.68%
—
−8.51%
+27.11%
—
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
2.50 B
5.00 B
7.50 B
10.00 B
Reported
Estimate
Currency: INR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
6.18 B
6.44 B
6.32 B
7.43 B
7.66 B
8.12 B
8.87 B
—
—
Estimate
6.20 B
6.67 B
7.18 B
6.89 B
—
7.67 B
7.55 B
8.29 B
—
Surprise
−0.18%
−3.51%
−11.98%
+7.78%
—
+5.79%
+17.48%
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
LUMAXIND EPS for the last quarter is 34.70 INR despite the estimation of 27.30 INR. In the next quarter EPS is expected to reach 32.70 INR. Track more of LUMAX INDUSTRIES LTD financials and stay on top of what is up with the company.
In the next quarter LUMAX INDUSTRIES LTD revenue is expected to reach 8.29 B INR. Check out LUMAX INDUSTRIES LTD revenue and earnings and make informed decisions.
According to analysts, LUMAXIND price target is 3,372.00 INR with a max estimate of 3,372.00 INR and a min estimate of 3,372.00 INR. Check if this forecast comes true in a year, meanwhile watch LUMAX INDUSTRIES LTD stock price chart and keep track of the current situation with LUMAXIND news and stock market news.